BCM
ANGO icon

Bluefin Capital Management’s AngioDynamics ANGO Stock Holding History

Bluefin Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-53,977
Closed -$900K – 939
2014
Q2 		$900K Hold
53,977
– – 0.04% 328
2014
Q1 		$900K Buy
+53,977
New +$879K 0.06% 232

Other funds holding ANGO

RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bluefin Capital Management's ANGO Position: Q3 2014 in Review

Bluefin Capital Management sold out of AngioDynamics (ANGO) in Q3 2014, closing a stake of 53,977 shares — an estimated $900K sold.

Bluefin Capital Management first reported a position in ANGO in Q1 2014 and held it in 2 quarters. The position peaked at $900K in Q2 2014. 105 funds tracked by Wall St. Rank hold ANGO as of Q3 2014.

  • Bluefin Capital Management reported no remaining AngioDynamics position as of Q3 2014 after selling out during the quarter.
  • Bluefin Capital Management sold 53,977 AngioDynamics shares in Q3 2014, an estimated $900K.
  • Bluefin Capital Management first reported a position in AngioDynamics in Q1 2014 and held it in 2 quarters.
  • Bluefin Capital Management's AngioDynamics position peaked at $900K in Q2 2014.
  • 105 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2014.

Based on Bluefin Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.